![Sample our Social Sciences journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/110822/TOC-Subject-Sample-2021-Social-Sciences.jpg"})
![Sociology:
Unlock the potential of your research by publishing fast, openly and without restrictions]({"type":"image" , "src" : "/sda/111118/JournalAdSubmissionSociologyF1000CK.jpg"})
![Publish your Policy Brief rapidly today and inspire change for tomorrow.]({"type":"image" , "src" : "/sda/110967/JournalAd-CFP-SociologyF1000.jpg"})
![Call for Papers.]({"type":"image" , "src" : "/sda/111134/JournalAdOASubmissionCAIC.jpg"})
ABSTRACT
The aim of this study was to measure the prevalence of FCR among a sample of French lymphoma survivors and to determine factors associated with clinical levels of FCR. The study was conducted with two cross-sectional measures: sociodemographic and anxiety, depression as well as health-related quality of life (HRQoL) scores were measured at the baseline of the post-cancer period and FCR was evaluated during the first 3 years of survivorship. The prevalence of clinical levels of FCR (≥13) was evaluated by the Fear of Cancer Recurrence Inventory – Short Form (FCRI-SF) among non- and Hodgkin lymphoma survivors undergoing prior first-line chemotherapy. Among 108 lymphoma survivors with an average follow-up of 1.6 years (range 0.3–3.0 years), clinical levels of FCR (≥13) were observed for 44.4% (n = 48). Multivariate analysis indicated that baseline anxiety and low quality of life were related to clinically significant FCR levels.
Acknowledgments
The authors express their gratefulness to the Fondation d’Avenir for their support.
Disclosure statement
No potential conflict of interest was reported by the authors.
Ethical compliance
The study received an agreement from the ethical committee number 37-0712.